Supplemental
. The Ada2 silencing function acts through SAGA, not SLIK/SALSA.
Diagram of C-terminal spt7 mutant alleles (78) tested for telomeric silencing.
spt7-200 lacks amino acids (aa) 1125-1150 (-200) containing the C-terminal proteolytic cleavage site (P); spt7-300 lacks aa 1151-1180 (-300) containing a domain mediating Spt8-association (S); spt7-400 lacks both these regions (-400).
Wild type, spt7-200 (LPY 10057), spt7-300 (LPY 10328), spt7-400 (LPY 10061) strains harboring a telomeric URA3 gene were plated on synthetic complete medium (growth) or synthetic complete medium containing 5-FOA (silencing) and assayed as in Fig. 1A . The spt7-200 mutant fails to make the proteolytic cleavage that creates the truncated form of Spt7 and is severely depleted for SLIK/SALSA (78). The spt7-200 strain did not have a telomeric silencing defect, indicating that SLIK/SALSA was not required for telomeric silencing. The spt7-300 mutant has predominantly SAGA-related complexes lacking Spt8 that elute from a Mono-Q column in the same fractions as SLIK/SALSA (78). This mutant had an intermediate silencing defect. The spt7-400 mutant lacks both regions and is depleted for SAGA (78). This strain was the most severely defective for telomeric silencing. A gcn5∆ spt7-400 double mutant (LPY 10258) was also defective for silencing, further supporting the conclusion that the SLIK/SALSA complex was not causing this defect.
FIG. S2. Deletion of ADA2 does not cause a significant mating defect. WT, ada2∆ and control strains containing the single mutants sir2∆, sir1∆, sas2∆, gcn5∆, or spt8∆ (upper two panels) and double mutant combinations of these genes (lower panels) are shown as mating patches in MATa and MATα strains as described in Fig. 2A . Strain numbers are listed in order of their presentation in the panels in Supplemental Table 1 . (B) Deletion of GCN5 does not suppress the galactose induced telomeric silencing defect. Cells were assayed as described in Fig. 1A . Cells were plated on synthetic complete medium containing 2% galactose (growth) or synthetic complete medium containing 2% galactose and 5-FOA (silencing).Note that there is a range of severity in the telomeric silencing defect in wild type cells grown on galactose. The silencing assay shown here illustrates a more severe silencing defect than in Fig. 7E . Although more severe, loss of GCN5 does not relieve the telomeric silencing defect upon growth in galactose, either as the sole mutation or in combination with an ada2 null mutation. An ada2∆ gcn5∆ control strain (LPY 8833) that is ura3-was included as a control for growth on 5FOA medium.
Other strains plated to assess telomeric silencing that contain a telomeric URA3 reporter gene (labeled Tel URA3 at left) are: wild type (LPY 8037), ada2∆ (LPY 8039), gcn5∆ (LPY 8719), and ada2∆ gcn5∆ (LPY 8805). Distance from telo (kb)
Gal MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1adh4::URA3-UAS-GAL -Telo VII-L ADE2 Tel V-R this study LPY 9966
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 ada2 ∆::KANMX adh4::URA3-UAS-GAL -Telo VII-L ADE2-Tel V-R this study LPY 9961
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1sir2 ∆::LEU2 ADE2 Tel V-R this study LPY 11806
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1gcn5 ∆::HIS3 ADE2 Tel V-R this study LPY 10910
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 ada3 ∆::KANMX adh4::URA3-UAS-GAL -Telo VII-L his study LPY 5843
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 spt8 ∆::KANMX adh4::URA3-UAS-GAL -Telo VII-L Jacobson and Pillus, 2003 LPY 9865
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 spt3 ∆::KANMX adh4::URA3-UAS-GAL -Telo VII-L this study LPY 9111
MAT ade2 his3 leu2, trp1 ura3 spt7 ∆::LEU2 adh4::URA3-UAS-GAL -Telo VII-L this study LPY 7880
MATαade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir2∆::TRP1 adh4::URA3 -Telo VII-L this study LPY 7888
MATαade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir3∆::TRP1 adh4::URA3 -Telo VII-L this study LPY 8036
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 adh4::URA3-UAS-GAL -Telo VII-L this study LPY 4624
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir2 ∆::TRP1 adh4::URA3-UAS-GAL -Telo VII-L Garcia and Pillus, 2002 LPY 8038
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 ada2 ∆::KANMX adh4::URA3-UAS-GAL -Telo VII-L this study LPY 9122
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir1 ∆::LEU2 sas2 ∆::HIS3 this study LPY 8044
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir1 ∆::LEU2 ada2 ∆::KANMX this study LPY 4638
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir2 ∆::TRP1 MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sas2 ∆::HIS3 w/ pLP1536 (HA control vector; 2u, TRP1 ) this study LPY 9832
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sas2 ∆::HIS3 w/ pLP1872 (3XHA-SAS2)CEN, URA3 ) this study LPY 9323
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir1 ∆::LEU2 sas2 ∆::TRP1 pLP126 (CEN, URA3 vector) this study LPY 9326
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir1 ∆::LEU2 sas2 ∆::TRP1 pLP1872(3XHA-SAS2) this study LPY 11
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir2 ∆::HIS3 LPY 8723
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 ada2 ∆::KANMX this study LPY 10
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir3 MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sas3∆::HIS3 LPY 12321
MATa ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir3∆::TRP1 gcn5∆::HIS3 this study LPY 12323
MATα ade2-1 his3-11,15 leu2,3-112 trp1-1 ura3-1 sir3∆::TRP1 sas3∆::HIS3 this study
